Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anish Majumdar"'
Autor:
Yuan Liu, Susan Thomas, Mohammad Zaidi, Shuhua Wang, Haydn Kissick, Gregory Lesinski, Alan Frey, Sruthi Ravindranathan, Edmund Waller, Michael Ware, Bassel El-rayes, Rohan Dhamsania, Jingru Zhu, Anish Majumdar, Brian Robinson, Maria Cardenas, Tenzin Passang Fnu, Jian Ming Li, Sanjeev Gumber, Shanmuganathan Chandrakasan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ef457d1db40045839ffa75158ef24e6a
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/ff93668538a74efb805c0ef4a5fbbfcf
Autor:
Edmund K. Waller, Maria Cardenas, Gregory B. Lesinski, Bassel F. El-Rayes, Jingru Zhu, Mohammad Y. Zaidi, Shuhua Wang, Brian S. Robinson, Michael B. Ware, Susan N. Thomas, Yuan Liu, Tenzin Passang Fnu, Shanmuganathan Chandrakasan, Sruthi Ravindranathan, Jian-Ming Li, Alan B. Frey, Rohan K. Dhamsania, Sanjeev Gumber, Anish Majumdar, Haydn T. Kissick
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPaucity of T cells in the immune privileged tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) is a major reason that PDAC is refractory to immune checkpoint blockade.1 In this study, we show that human PDAC tumors over
Autor:
Shuhua Wang, Gregory B. Lesinski, Bassel F. El-Rayes, Rohan K. Dhamsania, Susan N. Thomas, Sanjay Chandrasekaran, Brandon Ware, Mohammad Y. Zaidi, Edmund K. Waller, Sruthi Ravindranathan, Passang Tenzin, Anish Majumdar, Jingru Zhu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Pancreatic ductal adenocarcinoma (PDAC), the fourth leading cause of cancer related death in the U.S, has a 5-year survival rate of only 10%.1 The paucity of T cells in the immune privileged tumor microenvironment (TME) is a major limitati
Publikováno v:
Cell biology international. 34(10)
A major goal of human embryonic stem cell (hESC) research is to regulate differentiation through external means to generate specific cell types with high purity for regenerative medicine applications. Although all hESC lines express pluripotency-asso